Investors
DiagnoCure’s mission is to be the leading developer and provider of high-value diagnostics for the detection and management of cancer.
Latest News
Q4-2011 Results
Briefcase to Download
STOCK INFORMATION
| Symbol | TSX: CUR |
|---|---|
| Last trade | 0.69 |
| Open | 0.75 |
| Net change | -0.10 |
| High | 0.79 |
| Low | 0.66 |
| 52 week range | 0.49 - 1.07 |
| Volume | 33,700 |
| As of | 2012-02-03 14:29 EST |
| $CAN. Quotes are delayed. For information purposes only. |
|